Advanced search
Publication Cover
British Journal of Biomedical Science Volume 76, 2019 - Issue 2
Journal homepage
119
Views
2
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver disease

H ElalfyTropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, EgyptCorrespondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0002-5602-0989
ORCID Icon,
MA El-MaksoudTropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
,
S AbedTropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
,
MA El AzizTropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
,
AZ ElsamanoudyDepartment of Medical Biochemistry and Molecular biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt;Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Saudi Arabia
,
S M Abo El-khairDepartment of Medical Biochemistry and Molecular biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
,
MA MohamedPathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
,
W ElkashefPathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
,
K ZalataPathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
,
R FaragTropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
&
M ArafaTropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
 show all
Pages 101-103 | Received 20 Dec 2018, Accepted 05 Jan 2019, Published online: 22 Mar 2019

References

  • European Association for the Study of the Liver. Clinical practice guidelines for the management of nonalcoholic fatty liver disease. J Hepatol. 2016;64:1388–1402.
  • Younossi Z, Anstee QM, Marietti M, et al. Global burden of nafld and nash: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20.
  • Onyekwere CA, Ogbera AO, Samaila AA, et al. Nonalcoholic fatty liver disease: synopsis of current developments. Niger J Clin Pract. 2015;18:703–712.
  • Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–357.
  • Loria P, Lonardo A, Leonardi F, et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci. 2003;48:2173–2181.
  • Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2004;99:1316–1320.
  • De Luca-Johnson J, Wangensteen KJ, Hanson J, et al. Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease. Dig Dis Sci. 2016;61:2710–2720.
  • Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431–435.
  • Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321.
  • Tsuneyama K, Baba H, Kikuchi K, et al. Autoimmune features in metabolic liver disease: a single-center experience and review of the literature. Clin Rev Allergy Immunol. 2013;45:143–148.
  • Ravi S, Shoreibah M, Raff E, et al. Autoimmune markers do not impact clinical presentation or natural history of steatohepatitis related liver disease. Dig Dis Sci. 2015;60:3788–3793.
  • Yatsuji S, Hashimoto E, Kaneda H, et al. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol. 2005;40:1130–1138.
  • Fujii Y, Kawamura H, Kawamura T, et al. Co-appearance of autoantibody-producing B220 (low) B cells with NKT cells in the course of hepatic injury. Cell Immunol. 2010;260:105–112.
  • Naito T, Kawamura T, Bannai M, et al. Simultaneous activation of natural killer T cells and autoantibody production in mice injected with denatured syngeneic liver tissue. Clin Exp Immunol. 2002;129:397–404.
  • Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis. 2002;22:339.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.